Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study

References

• Ye H, Liu H, Attygalle A, . Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites:significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 2003;102:1012–1018.
   PubMed Web of Science ®Google Scholar
• Streubel B, Simonitsch-Klupp I, Müllauer L, . Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004;18:1722–1726.
   PubMed Web of Science ®Google Scholar
• Inagaki H, Nakamura T, Li C, . Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol 2004;28:1560–1567.
   PubMed Web of Science ®Google Scholar
• Dierlamm J, Baens M, Wlodarska I, . The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999;93:3601–3609.
   PubMed Web of Science ®Google Scholar
• Liu H, Ye H, Ruskone-Fourmestraux A, . t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;122:1286–1294.
   PubMed Web of Science ®Google Scholar
• Tibiletti MG, Milani K, Martin V, . Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type. Hematol Oncol 2007;25:184–188.
   PubMed Web of Science ®Google Scholar
• Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?Br J Haematol 2007;136:521–538.
   PubMed Web of Science ®Google Scholar
• Hammel P, Haioun C, Chaumette MT, . Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995;13:2524–2529.
   PubMed Web of Science ®Google Scholar
• Lévy M, Copie-Bergman C, Traulle C, . Conservative treatment of primary gastric low grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol 2002;97:292–297.
   PubMed Web of Science ®Google Scholar
• Lévy M, Copie-Bergman C, Gameiro C, . Prognostic value of translocation t(11;18) in tumoural response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol 2005;23:5061–5066.
   PubMed Web of Science ®Google Scholar
• Raderer M, Jager G, Brugger S, . Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 2003;65:306–310.
   PubMed Web of Science ®Google Scholar
• Conconi A, Martinelli G, Thieblemont C, . Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102:2741–2745.
   PubMed Web of Science ®Google Scholar
• Martinelli G, Laszlo D, Ferreri AJ, . Clinical activity of rituximab in gastric marginal zone non Hodgkin's lymphoma resistant to or non eligible for anti-Helicobacter pylori therapy. J Clin Oncol 2005;23:1979–1983.
   PubMed Web of Science ®Google Scholar
• Lévy M, Copie-Bergman C, Molinier-Frenkel V, . Treatment of t(11;18)-positive gastric MALT lymphoma with rituximab and chlorambucil: clinical, histological and molecular follow-up. Leuk Lymphoma 2010;51:284–290.
   PubMed Web of Science ®Google Scholar
• Musshoff K. Klinische stadieneinteilung der nicht-Hodgkin lymphome. Strahlentherapie 1977;153:218–221.
   PubMedGoogle Scholar
• Lévy M, Hammel P, Lamarque D, . Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. Gastrointest Endosc 1997;46:328–333.
   PubMed Web of Science ®Google Scholar
• Isaacson PG, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:1410–1416.
   Google Scholar
• Tankovic J, Chaumette-Planckaert MT, Deforges L, . Routine use of real-time PCR for detection of Helicobcater pylori and of clarithromycin resistance mutations. Gastroenterol Clin Biol 2007;31:792–795.
   PubMed Web of Science ®Google Scholar
• Copie-Bergman C, Gaulard P, Lavergne-Slove A, . Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 2003;52:1656.
   PubMed Web of Science ®Google Scholar
• Martinelli G, Laszlo D, Bertolini F, . Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma. Br J Haematol 2003; 123:271–277.
   PubMed Web of Science ®Google Scholar
• Ruskoné-Fourmestraux A, Fischbach W, Aleman BM, . EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 2011;60:747–758.
   PubMed Web of Science ®Google Scholar
• Streubel B, Ye H, Du MQ, . Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Oncology 2004;66:476–480.
   PubMed Web of Science ®Google Scholar
• Zinzani PL, Stefoni V, Musuraca G, . Fludarabine-containing chemotherapy as frontline treatment of non gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 2004;100:2190–2194.
   PubMed Web of Science ®Google Scholar
• de Boer JP, Raderer M, Van Tinteren H . Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment. Leuk Lymphoma 2011;52:2262–2269.
   PubMed Web of Science ®Google Scholar
• Brown JR, Friedberg JW, Feng Y, . A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol 2009;145:741–748.
   PubMed Web of Science ®Google Scholar
• Salar A, Domingo-Domenec E, Estany C, . Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer 2009;115:5210–5217.
   PubMed Web of Science ®Google Scholar
• Zucca E, Conconi A, Martinelli M, . Chlorambucil plus rituximab produces better event-free survival in comparison to chlorambucil alone in the treatment of MALT lymphoma: 5-year analysis of the 2-arms part of the IELSG 19 randomized study. Blood 2010;116(Suppl. 1): Abstract 432.
   Google Scholar